Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, A Skiada, R Andini, N Eliakim-Raz, A Nutman, O Zusman, A Antoniadou, PC Pafundi, A Adler, Y Dickstein, I Pavleas, R Zampino, V Daitch, R Bitterman, H ZayyadF Koppel, I Levi, T Babich, LE Friberg, Johan Mouton, U Theuretzbacher, L Leibovici

Research output: Contribution to journalArticleAcademic

396 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)391-400
Number of pages10
JournalLancet Infectious Diseases
Issue number4
Publication statusPublished - 2018

Research programs

  • EMC MM-04-28-01

Cite this